首页|氨溴特罗口服液对小儿喘息性疾病的疗效观察

氨溴特罗口服液对小儿喘息性疾病的疗效观察

扫码查看
目的分析氨溴特罗口服液用于治疗小儿喘息性疾病的临床疗效.方法收集2011年1月-2012年12月间我院收治的喘息性疾病患儿80例,随机分为观察组和对照组各40例,观察组予以氨溴特罗口服液进行治疗,对照组予以小儿咳喘灵进行治疗,观察两组疗效.结果观察组治疗总有效率为97.5%,高于对照组的87.5%(P <0.05);观察组各项症状消失时间明显较对照组短,且观察组未发现不良反应,对照组不良反应率为7.5%,组间差异明显(P <0.05).结论氨溴特罗口服液用于治疗小儿喘息性疾病疗效显著,安全可靠,不良反应少,值得推广应用.
Objective Analysis of ambrocol oral solution for the clinical curative effect of the treatment of children with asthmatic diseases. Methods 2011 January to 2012 December were collected during children with asthmatic disease in our hospital, 80 cases, were randomly divided into two groups, the observation group 40 cases were given ambrocol oral liquid for treatment, the control group of 40 cases of pediatric cough treatment, the efficacy was observed in two groups. Results The observation group the total effective rate was 97.5%, significantly higher than that of the control group 87.5%(P <0.05); the symptoms disappear time of observation group was significantly shorter than that of the control group and the observation group, no adverse reaction was found in control group, the adverse reaction rate was 7.5%, the difference between the two groups was significant(P <0.05). Conclusion Conclusion ambrocol oral solution for the treatment of children with asthmatic disease curative effect is remarkable, safe and reliable, less adverse reactions, it is worthy of popularization and application.

Asthmatic diseaseConclusion ambrocol oral solutionThe clinical curative effect

陈立琼

展开 >

610300 四川省成都市青白江区人民医院

喘息性疾病 氨溴特罗口服液 临床疗效

2013

中国医疗前沿
中国医院协会

中国医疗前沿

影响因子:0.186
ISSN:1673-5552
年,卷(期):2013.(6)
  • 4
  • 2